欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4117/002
药品名称
Atazanavir Sandoz 150 mg, harde capsules
活性成分
Atazanavir sulfate 171.0 mg
剂型
Capsule, hard
上市许可持有人
Sandoz B.V. Almere Netherlands
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
许可日期
2018/09/19
最近更新日期
2024/12/18
药物ATC编码
J05AE08 atazanavir
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
1_3_1 spc_label_pl _ common_outer _ 5_857
Date of last change:2024/09/06
PubAR
|
190723 NL_H_4117_001_004_DC Atazanavir Sandoz PAR
Date of last change:2024/09/06
PubAR Summary
|
190723 NL_H_4117_001_004_DC Atazanavir Sandoz summary EN
Date of last change:2024/09/06
Final Product Information
|
common_outer _ clean
Date of last change:2024/09/06
Final PL
|
common_pl
Date of last change:2024/09/06
Final Product Information
|
common_pl _ clean
Date of last change:2024/09/06
Final SPC
|
common_spc
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase